pharmidex publications

2005

• CNS Drug Discovery: Challenges and Solutions.Drugs News Perspect., 18:51-57.


• Population aging: A challenge for CNS drug discovery GOR 7:46-48
• Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery NeuroRx 2: 554–571

2004

• The pivotal role of drug metabolism and pharmacokinetics in research and development.
  iDrugs, 7: 755-763
• Systems biology and the discovery and development of new medicines for CNS disorders DrugPlus International, Sept, 10-12.
  

2003

• Comparison of human recombinant adenosine A2B receptor function assessed by Fluo-3-AM fluorometry and microphysiometry.
  Brit. J. Pharmacol., 138: 371-677.
• New Horizons in Drug Metabolism, Pharmacokinetics.
  Drug News Perspect., 16: 1-6.
• Cholinergic Therapies for Alzheimer’s disease: Progress and Prospects. Curr Opin in Investig Drugs., 4: 833-840.
• Effectively meeting the need for long-term neurological care.
  Current Drug Discovery, July.
• Striatal neurones show sustained recovery from severe hypoglycaemic insult.
  J Neurochem., 86: 383-393
• Pharmacological characterisation of positive modulatory metabotropic glutamate receptors on rapidly superfused rat cerebrocortical excitatory amino acid releasing nerve terminals.
  J. Neurochem., 86:1346-1358
• Pharmacotherapy of neuropathic pain: Progress and prospects.
  Drug News and Perspectives, 16: 622-630

2002

• Pharmacotherapy for Alzheimer’s disease: progress and prospects. Trends Pharmacol. Sci., 23: 426-433.